Arshpreet Singh Badesha

Arshpreet Singh Badesha

Auto-generated profile, based on publicly available information

Arshpreet Singh Badesha

Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
ABArshpreet Singh Badesha
Arshpreet Singh Badesha
PBPrab Rajan Singh Bains
Prab Rajan Singh Bains
BBBal Rajan Singh Bains
Bal Rajan Singh Bains
TKTaha Khan
Taha Khan

18 January 2022 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
ABArshpreet Singh Badesha
Arshpreet Singh Badesha
MSMuhammad Mubashir Siddiqui
Muhammad Mubashir Siddiqui
BBBal Rajan Singh Bains
Bal Rajan Singh Bains
PBPrab Rajan Singh Bains
Prab Rajan Singh Bains
TKTaha Khan
Taha Khan

17 May 2022 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
ABArshpreet Singh Badesha
Arshpreet Singh Badesha
TKTaha Khan
Taha Khan
EAEngy Abdellatif
Engy Abdellatif
Adrenocortical carcinoma (ACC) is a rare form of cancer with an annual incidence of two per million. The risk of venous thromboembolism increases sevenfold in patients with cancer. This case report describes an iliac vein deep vein thrombosis (DVT) as an atypical presentation of an ACC and highlights the value of further imaging investigation in patients with unprovoked DVTs.

25 August 2021 in Cureus
Verified
Journal Article
Open access
ABArshpreet Singh Badesha
Arshpreet Singh Badesha
KTKajal Kaur Tamber
Kajal Kaur Tamber
KPKatarzyna Powezka
Katarzyna Powezka
SHStacie Hodge
Stacie Hodge
TKTaha Khan
Taha Khan
Deep vein thrombosis (DVT) is a frequent complication in patients suffering from inflammatory bowel disease (IBD), especially in those with frequent relapses of the disease or extensive inflammatory lesions. The aetiology for the increased risk is multifactorial. Current evidence on management of acute iliofemoral DVT in IBD patients is scarce. This case series highlights two cases of active IBD, who developed acute iliofemoral DVTs and were treated with catheter-directed thrombolysis (CDT). This report demonstrates that CDT is effective in clearing the clot burden and producing significant symptomatic improvement in the absence of major complications. An individualised approach must be taken for the management of IBD patients with acute iliofemoral DVT.

17 November 2021 in Radiology Case Reports
Verified
Journal Article
Open access
ABArshpreet Singh Badesha
Arshpreet Singh Badesha
GKGhazn Khan
Ghazn Khan
TKTaha Khan
Taha Khan
Symptomatic inferior vena cava (IVC) and iliac vein thrombosis is increasingly being treated with thrombolysis, thrombus retrieval and deep venous stenting. If the IVC stent occludes, endovenous intervention is indicated to restore patency. An 18-year-old male with Behçet's disease presented with deep vein thrombosis (extending from the IVC to the popliteal segments bilaterally) which was initially treated with thrombolysis and stenting. Fifteen months later, the patient experienced symptomatic deterioration; a chronically-occluded IVC stent was identified and reconstructed using a double-barrel stenting technique. Patient compliance to post-stenting anticoagulation therapy is paramount to maintain stent patency. A multi-disciplinary approach including haematologists can be beneficial for patients with a background of thrombophilic disorders.